The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines

<i>Background:</i> Approximately 10–20% of subjects vaccinated with HBsAg-based hepatitis B virus (HBV) vaccines are non-responders. BM32 is a recombinant grass pollen allergy vaccine containing the HBV-derived preS surface antigen as an immunological carrier protein. PreS includes the binding site...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Inna Tulaeva, Felix Lehmann, Nora Goldmann, Alexandra Dubovets, Daria Trifonova, Mikhail Tulaev, Carolin Cornelius, Milena Weber, Margarete Focke-Tejkl, Alexander Karaulov, Rainer Henning, David Niklas Springer, Ursula Wiedermann, Dieter Glebe, Rudolf Valenta
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2024-09-01
Sarja:	Vaccines
Aiheet:	HBV vaccines preS surface protein HBsAg non-responsiveness
Linkit:	https://www.mdpi.com/2076-393X/12/10/1123
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!